Insiders · MGRX

MGRX insider transactions

Mangoceuticals Inc. (MGRX) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for MGRX

• 36d
  SEC Form 4 filed by Cohen Jacob D.

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 36d
  SEC Form 4 filed by Cohen Jacob D.

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 129d
  CFO Johnston Eugene M sold $3,884 worth of shares (3,333 units at $1.17), decreasing direct ownership by 3% to 120,000 units (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 135d
  CFO Johnston Eugene M sold $5,975 worth of shares (5,000 units at $1.20), decreasing direct ownership by 4% to 123,333 units (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 137d
  CFO Johnston Eugene M sold $11,280 worth of shares (10,000 units at $1.13), decreasing direct ownership by 7% to 128,333 units (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 150d
  Director Hamilton Alex P. sold $152,875 worth of shares (125,000 units at $1.22), decreasing direct ownership by 97% to 3,334 units (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 207d
  Chief Executive Officer Cohen Jacob D. was granted 200,000 shares (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 225d
  Director D'Alessio Lorraine Pamela was granted 100,000 shares, increasing direct ownership by 273% to 136,667 units (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 225d
  Chief Financial Officer Johnston Eugene M was granted 100,000 shares, increasing direct ownership by 261% to 138,334 units (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 225d
  Director Myers Kenny was granted 100,000 shares, increasing direct ownership by 273% to 136,667 units (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 225d
  Director Hamilton Alex P. was granted 100,000 shares, increasing direct ownership by 375% to 126,667 units (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 459d
  New insider Isaac Antonios claimed no ownership of stock in the company (SEC Form 3)

  3 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 529d
  Chief Financial Officer Johnston Eugene M was granted 25,000 shares, increasing direct ownership by 187% to 38,334 units (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 606d
  Chief Executive Officer Cohen Jacob D. gifted 800,000 shares and received a gift of 800,000 shares (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 667d
  Director Hamilton Alex P. sold $39,834 worth of shares (125,000 units at $0.32), decreasing direct ownership by 71% to 50,000 units (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 689d
  D'Alessio Lorraine Pamela was granted 100,000 shares, increasing direct ownership by 133% to 175,000 units (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 689d
  Hamilton Alex P. was granted 100,000 shares, increasing direct ownership by 133% to 175,000 units (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 689d
  Hammer Amanda Elizabeth was granted 100,000 shares, increasing direct ownership by 133% to 175,000 units (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 689d
  Cohen Jacob D. was granted 800,000 shares (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)
• 689d
  Myers Kenny was granted 100,000 shares, increasing direct ownership by 133% to 175,000 units (SEC Form 4)

  4 - MANGOCEUTICALS, INC. (0001938046) (Issuer)